The Medical-Surgical Journal · Jun 20, 2026
IN VIVO BIOCOMPATIBILITY EVALUATION OF NORFLOXACIN-LOADED CHITOSAN NANOFIBERS AND BORONIC ALDEHYDE-FUNCTIONALIZED DERIVATIVES IN RAT
0Sign in to vote or save
This site took too long to answer. You can still read it on the original site — the toolbar below keeps your place in the directory.
Chitosan-based nanofibers can serve as carriers for antimicrobial agents, providing controlled drug release and biocompatibility, which are crucial for tissue integration and healing. This study aimed to evaluate the in vivo biocompatibility of norfloxacin-loaded chitosan nanofibers (NorC) and norfloxacin-loaded chitosan nanofibers functionalized with boronic aldehyde (NorCB), in comparison with…

Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.